Vepdegestrant, a PROTAC Estrogen Receptor Degrader, in Advanced Breast Cancer
Article Details
Journal Info
New England Journal of Medicine
Massachusetts Medical Society
Authors (27)
Mario Campone
Institut de Cancérologie de l’Ouest Angers-Nantes, Saint-Herblain, France
Michelino De Laurentiis
Istituto Nazionale Tumori IRCCS “Fondazione G. Pascale,” Naples, Italy
Komal Jhaveri
Memorial Sloan Kettering Cancer Center, New York
Xichun Hu
Shanghai Cancer Center, Fudan University, Shanghai, China
Sylvain Ladoire
Centre Georges Francois Leclerc, Dijon, France
Anne Patsouris
Institut de Cancérologie de l’Ouest Angers-Nantes, Angers, France
Claudio Zamagni
IRCCS Azienda Ospedaliero Universitaria di Bologna, Bologna, Italy
Jiuwei Cui
Marina Cazzaniga
Phase 1 Research Unit, Fondazione IRCCS San Gerardo, Monza, Italy
Timuçin Çil
Adana City Education and Research Hospital, Adana Faculty of Medicine, University of Health Sciences, Adana, Turkey
Katarzyna J. Jerzak
Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto
Christian Fuentes
Fundación Respirar, Buenos Aires
Tetsuhiro Yoshinami
Graduate School of Medicine, Osaka University, Osaka, Japan
Alvaro Rodriguez-Lescure
Hospital General Universitario de Elche, Elche, Spain
Ahmet Sezer
Baskent University Adana Application and Research Center, Adana, Turkey
Andrea Fontana
Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy
Valentina Guarneri
Veneto Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico, Padua, Italy
Andrea Molckovsky
Grand River Regional Cancer Centre, Kitchener, ON, Canada
Marie-Ange Mouret-Reynier
Centre Jean Perrin, Clermont-Ferrand, France
Umut Demirci
Memorial Ankara Hospital, Ankara, Turkey
Yongqiang Zhang
Olga Valota
Pfizer, Milan
Dongrui R Lu
Pfizer, San Diego, CA
Marcella Martignoni
Pfizer, Milan
Janaki Parameswaran
Arvinas Operations, New Haven, CT
Xin Zhi
Arvinas Operations, New Haven, CT
Erika P. Hamilton
Breast Cancer Research Program, Sarah Cannon Research Institute, Nashville